Advertisement
Research Article| Volume 360, P27-33, November 2022

Changes in metabolic syndrome burden and risk of coronary artery calcification progression in statin-naïve young adults

  • Author Footnotes
    1 These authors contributed equally to this work as first authors.
    Hyo-Jeong Ahn
    Footnotes
    1 These authors contributed equally to this work as first authors.
    Affiliations
    Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this work as first authors.
    Heesun Lee
    Footnotes
    1 These authors contributed equally to this work as first authors.
    Affiliations
    Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea

    Division of Cardiology, Seoul National University Hospital Healthcare System Gangnam Centre, Seoul, Republic of Korea
    Search for articles by this author
  • Hyo Eun Park
    Affiliations
    Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea

    Division of Cardiology, Seoul National University Hospital Healthcare System Gangnam Centre, Seoul, Republic of Korea
    Search for articles by this author
  • Donghee Han
    Affiliations
    Department of Imaging, Cedars-Sinai Medical Centre, Los Angeles, CA, USA
    Search for articles by this author
  • Hyuk-Jae Chang
    Affiliations
    Division of Cardiology, Yonsei Cardiovascular Centre, Yonsei University Health System, Seoul, Republic of Korea
    Search for articles by this author
  • Eun Ju Chun
    Affiliations
    Division of Radiology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
    Search for articles by this author
  • Hae-Won Han
    Affiliations
    Department of Internal Medicine, Gangnam Heartscan Clinic, Seoul, Republic of Korea
    Search for articles by this author
  • Jidong Sung
    Affiliations
    Division of Cardiology, Heart Stroke & Vascular Institute, Samsung Medical Centre, Seoul, Republic of Korea
    Search for articles by this author
  • Hae Ok Jung
    Affiliations
    Division of Cardiology, Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea
    Search for articles by this author
  • Su-Yeon Choi
    Correspondence
    Corresponding author. Healthcare System Gangnam Centre, Seoul National University Hospital, 39th floor, Gangnam Finance Centre 737, Yeoksam-dong, Gangnam-gu, Seoul, 06236, Republic of Korea.
    Affiliations
    Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea

    Division of Cardiology, Seoul National University Hospital Healthcare System Gangnam Centre, Seoul, Republic of Korea
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this work as first authors.

      Highlights

      • The presence of metabolic syndrome (MetS) increased the risk of coronary artery calcification (CAC) progression with approximately 1.83-fold, and the risk of CAC progression was directly proportional to the metabolic burden.
      • Among the metabolic components, elevated blood pressure and triglycerides level independently contributed to CAC progression.
      • A significant reduction in metabolic burdens was associated with a halved risk of CAC progression in young adults having MetS, suggesting optimization of cardiovascular profiles in early adulthood might play a preventive role for CAC progression.

      Abstract

      Background and aims

      We aimed to investigate the association between metabolic syndrome (MetS) and coronary artery calcium (CAC) progression in statin-naïve young adults.

      Methods

      From the KOrea Initiatives on Coronary Artery calcification registry, we included asymptomatic young adults aged 20–45 years who underwent serial CAC scans for routine health check-ups. The primary endpoint was CAC progression. We estimated the risk of CAC progression based on the presence and burden of MetS. Among participants with MetS, the temporal relationship between changes in metabolic burden and CAC progression was evaluated.

      Results

      Of 2151 young adults (mean age 41.3 ± 3.8 years; male 85.4%), 488 (22.7%) had MetS. The mean CAC score was 10.8 and 81.3% of them had a CAC score of zero at baseline. During follow-up (median, 2.1 years), CAC progression was observed in 325 (15.1%) adults. MetS was associated with an approximately 1.8-fold increased risk of CAC progression (adjusted hazard ratio [aHR] 1.83, p < 0.001). The risk of CAC progression was directly proportional to the metabolic burden. Elevated blood pressure and elevated triglyceride levels were independent components related to CAC progression, with the strongest contribution being made by elevated blood pressure (aHR 2.00, p < 0.001). A reduction in at least two metabolic burdens was associated with a halved risk of CAC progression in young adults having MetS (odds ratio 0.41, p = 0.018).

      Conclusions

      In statin-naïve young adults, the metabolic burden was associated with a risk of CAC progression in a dose-dependent manner. Improvement in metabolic imbalance may have a preventive effect on CAC progression.

      Graphical abstract

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Andersson C.
        • Vasan R.S.
        Epidemiology of cardiovascular disease in young individuals.
        Nat. Rev. Cardiol. 2018; 15: 230-240
        • Benjamin E.J.
        • Blaha M.J.
        • Chiuve S.E.
        • et al.
        Heart disease and stroke statistics-2017 update: a report from the American heart association.
        Circulation. 2017; 135: e146-e603
        • Sulo G.
        • Igland J.
        • Nygard O.
        • et al.
        Favourable trends in incidence of AMI in Norway during 2001-2009 do not include younger adults: a CVDNOR project.
        Eur. J. Prev. Cardiol. 2014; 21: 1358-1364
        • Wang X.
        • Gao M.
        • Zhou S.
        • et al.
        Trend in young coronary artery disease in China from 2010 to 2014: a retrospective study of young patients </= 45.
        BMC Cardiovasc. Disord. 2017; 17: 18
        • Roth G.A.
        • Mensah G.A.
        • Johnson C.O.
        • et al.
        Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study.
        J. Am. Coll. Cardiol. 2020; 76: 2982-3021
        • Vasan R.S.
        • Zachariah J.P.
        • Xanthakis V.
        Life course developmental approach to cardiovascular health and cardiovascular disease prevention: opportunities and unanswered questions.
        J. Am. Coll. Cardiol. 2020; 76: 2708-2711
        • Pletcher M.J.
        • Tice J.A.
        • Pignone M.
        • et al.
        Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis.
        Arch. Intern. Med. 2004; 164: 1285-1292
        • Han D.
        • Oh B.
        • Gransar H.
        • et al.
        Incremental benefit of coronary artery calcium score above traditional risk factors for all-cause mortality in asymptomatic Korean adults.
        Circ. J. 2015; 79: 2445-2451
        • Malik S.
        • Zhao Y.
        • Budoff M.
        • et al.
        Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the multi-ethnic study of atherosclerosis.
        JAMA Cardiol. 2017; 2: 1332-1340
        • Ekblom-Bak E.
        • Ekblom O.
        • Fagman E.
        • et al.
        Fitness attenuates the prevalence of increased coronary artery calcium in individuals with metabolic syndrome.
        Eur. J. Prev. Cardiol. 2018; 25: 309-316
        • Stone N.J.
        • Smith Jr., S.C.
        • Orringer C.E.
        • et al.
        Managing atherosclerotic cardiovascular risk in young adults: JACC state-of-the-art review.
        J. Am. Coll. Cardiol. 2022; 79: 819-836
        • Polonsky T.S.
        • McClelland R.L.
        • Jorgensen N.W.
        • et al.
        Coronary artery calcium score and risk classification for coronary heart disease prediction.
        JAMA. 2010; 303: 1610-1616
        • Grundy S.M.
        • Stone N.J.
        • Bailey A.L.
        • et al.
        Guideline on the management of blood cholesterol: a report of the American College of cardiology/American heart association task force on clinical practice guidelines.
        Circulation. 2018; 139 (AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA 2019): e1082-e1143
        • Alberti K.G.
        • Eckel R.H.
        • Grundy S.M.
        • et al.
        Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, Lung, and blood Institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity.
        Circulation. 2009; 120: 1640-1645
        • Ahn H.J.
        • Han K.D.
        • Choi E.K.
        • et al.
        Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study.
        Cardiovasc. Diabetol. 2021; 20: 20
        • Kim L.K.
        • Yoon J.W.
        • Lee D.H.
        • et al.
        Impact of metabolic syndrome on the progression of coronary calcium and of coronary artery disease assessed by repeated cardiac computed tomography scans.
        Cardiovasc. Diabetol. 2016; 15: 92
        • Wong N.D.
        • Nelson J.C.
        • Granston T.
        • et al.
        Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: the Multiethnic Study of Atherosclerosis study.
        JACC Cardiovasc. Imag. 2012; 5: 358-366
        • Lee W.
        • Yoon Y.E.
        • Kwon O.
        • et al.
        Evaluation of coronary artery calcium progression in asymptomatic individuals with an initial score of zero.
        Kor. Circ. J. 2019; 49: 448-457
        • Lee W.
        • Yoon Y.E.
        • Cho S.Y.
        • et al.
        Sex differences in coronary artery calcium progression: the Korea Initiatives on Coronary Artery Calcification (KOICA) registry.
        PLoS One. 2021; 16e0248884
        • Seo M.H.
        • Lee W.Y.
        • Kim S.S.
        • et al.
        Korean society for the study of obesity guideline for the management of obesity in Korea.
        J Obes Metab Syndr. 2018; 28 (2019): 40-45
        • Grundy S.M.
        • Cleeman J.I.
        • Daniels S.R.
        • et al.
        Diagnosis and management of the metabolic syndrome: an American heart association/National heart, Lung, and blood Institute scientific statement.
        Circulation. 2005; 112: 2735-2752
        • Alberti K.G.
        • Zimmet P.
        • Shaw J.
        • et al.
        The metabolic syndrome--a new worldwide definition.
        Lancet. 2005; 366: 1059-1062
        • Agatston A.S.
        • Janowitz W.R.
        • Hildner F.J.
        • et al.
        Quantification of coronary artery calcium using ultrafast computed tomography.
        J. Am. Coll. Cardiol. 1990; 15: 827-832
        • Paixao A.R.M.
        • Neeland I.J.
        • Ayers C.R.
        • et al.
        Defining coronary artery calcium concordance and repeatability - implications for development and change: the Dallas Heart Study.
        J. Cardiovasc. Comput. Tomogr. 2017; 11: 347-353
        • Lakka H.M.
        • Laaksonen D.E.
        • Lakka T.A.
        • et al.
        The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
        JAMA. 2002; 288: 2709-2716
        • Lee H.
        • Park J.B.
        • Hwang I.C.
        • et al.
        Association of four lipid components with mortality, myocardial infarction, and stroke in statin-naive young adults: a nationwide cohort study.
        Eur. J. Prev. Cardiol. 2020; 27: 870-881
        • Park J.B.
        • Kim D.H.
        • Lee H.
        • et al.
        Effect of moderately but persistently elevated lipid levels on risks of stroke and myocardial infarction in young Korean adults.
        J. Am. Heart Assoc. 2021; 10e020050
        • Cardoso R.
        • Generoso G.
        • Staniak H.L.
        • et al.
        Predictors of coronary artery calcium incidence and progression: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
        Atherosclerosis. 2020; 309: 8-15
        • Gassett A.J.
        • Sheppard L.
        • McClelland R.L.
        • et al.
        Risk factors for long-term coronary artery calcium progression in the multi-ethnic study of atherosclerosis.
        J. Am. Heart Assoc. 2015; 4e001726
        • Luo D.
        • Cheng Y.
        • Zhang H.
        • et al.
        Association between high blood pressure and long term cardiovascular events in young adults: systematic review and meta-analysis.
        BMJ. 2020; 370: m3222
        • De Venecia T.
        • Lu M.
        • Figueredo V.M.
        Hypertension in young adults.
        Postgrad. Med. 2016; 128: 201-207
        • Son J.S.
        • Choi S.
        • Kim K.
        • et al.
        Association of blood pressure classification in Korean young adults according to the 2017 American College of cardiology/American heart association guidelines with subsequent cardiovascular disease events.
        JAMA. 2018; 320: 1783-1792
        • Xanthakis V.
        • Sung J.H.
        • Samdarshi T.E.
        • et al.
        Relations between subclinical disease markers and type 2 diabetes, metabolic syndrome, and incident cardiovascular disease: the Jackson Heart Study.
        Diabetes Care. 2015; 38: 1082-1088
        • Detrano R.
        • Guerci A.D.
        • Carr J.J.
        • et al.
        Coronary calcium as a predictor of coronary events in four racial or ethnic groups.
        N. Engl. J. Med. 2008; 358: 1336-1345
        • Budoff M.J.
        • Hokanson J.E.
        • Nasir K.
        • et al.
        Progression of coronary artery calcium predicts all-cause mortality.
        JACC Cardiovasc. Imag. 2010; 3: 1229-1236
        • Lehmann N.
        • Erbel R.
        • Mahabadi A.A.
        • et al.
        Value of progression of coronary artery calcification for risk prediction of coronary and cardiovascular events: result of the HNR study (Heinz Nixdorf Recall).
        Circulation. 2018; 137: 665-679
        • Budoff M.J.
        • Young R.
        • Lopez V.A.
        • et al.
        Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis).
        J. Am. Coll. Cardiol. 2013; 61: 1231-1239
        • Blaha M.J.
        • Cainzos-Achirica M.
        • Greenland P.
        • et al.
        Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the multi-ethnic study of atherosclerosis (MESA).
        Circulation. 2016; 133: 849-858
        • Razavi A.C.
        • Wong N.
        • Budoff M.
        • et al.
        Predicting long-term absence of coronary artery calcium in metabolic syndrome and diabetes: the MESA study.
        JACC Cardiovasc. Imag. 2021; 14: 219-229
        • Javaid A.
        • Mitchell J.D.
        • Villines T.C.
        Predictors of coronary artery calcium and long-term risks of death, myocardial infarction, and stroke in young adults.
        J. Am. Heart Assoc. 2021; 10e022513
        • Carr J.J.
        • Jacobs Jr., D.R.
        • Terry J.G.
        • et al.
        Association of coronary artery calcium in adults aged 32 to 46 Years with incident coronary heart disease and death.
        JAMA Cardiol. 2017; 2: 391-399